Teva Pharmaceuticals International GmbH et al v. Lupin, Ltd. et al > Summary
Court Case Number 1:19-cv-01251
Filing Date Jul 2, 2019
Termination Date Mar 11, 2020
Court Delaware District Court
Status Dismissed - Settled
JudgesColm F. Connolly
Plaintiff Attorneys
35TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: David I. Berl
Williams & Connolly
Teva Pharmaceuticals
Attorney Name: Adam D. Harber
Williams & Connolly
Teva Pharmaceuticals
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Teva Pharmaceuticals
Attorney Name: Ben V. Picozzi
Williams & Connolly
Teva Pharmaceuticals
Attorney Name: Elise M. Baumgarten
Williams & Connolly
Teva Pharmaceuticals
Attorney Name: Daniel G. Brown
Latham & Watkins
Teva Pharmaceuticals
Attorney Name: Michelle L. Ernst
Latham & Watkins
Teva Pharmaceuticals
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Teva Pharmaceuticals
Attorney Name: Marc N. Zubick
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: Adam D. Harber
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Cephalon (Teva)
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Ben V. Picozzi
Williams & Connolly
Cephalon (Teva)
Attorney Name: Ben V. Picozzi
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Elise M. Baumgarten
Williams & Connolly
Cephalon (Teva)
Attorney Name: Elise M. Baumgarten
Williams & Connolly
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel G. Brown
Latham & Watkins
Cephalon (Teva)
Attorney Name: Daniel G. Brown
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Michelle L. Ernst
Latham & Watkins
Cephalon (Teva)
Attorney Name: Michelle L. Ernst
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Cephalon (Teva)
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Marc N. Zubick
Latham & Watkins
Cephalon (Teva)
Attorney Name: Marc N. Zubick
Latham & Watkins
Defendant Attorneys
14Lupin Limited
Attorney Name: Kevin P. Burke
Rakoczy Molino Mazzochi Siwik
Lupin Limited
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Lupin Limited
Attorney Name: Melvin W. Gaddy
Rakoczy Molino Mazzochi Siwik
Lupin Limited
Attorney Name: Jeffrey A. Marx
Rakoczy Molino Mazzochi Siwik
Lupin Limited
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik
Lupin Limited
Attorney Name: Paul John Molino
Rakoczy Molino Mazzochi Siwik
Lupin Limited
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Lupin Pharmaceuticals
Attorney Name: Kevin P. Burke
Rakoczy Molino Mazzochi Siwik
Lupin Pharmaceuticals
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Lupin Pharmaceuticals
Attorney Name: Melvin W. Gaddy
Rakoczy Molino Mazzochi Siwik
Lupin Pharmaceuticals
Attorney Name: Jeffrey A. Marx
Rakoczy Molino Mazzochi Siwik
Lupin Pharmaceuticals
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik
Lupin Pharmaceuticals
Attorney Name: Paul John Molino
Rakoczy Molino Mazzochi Siwik
Lupin Pharmaceuticals
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10052385 | Formulations of bendamustine | Aug 21, 2018 |
| 10010533 | Formulations of bendamustine | Jul 3, 2018 |
| 09597397 | Formulations of bendamustine | Mar 21, 2017 |
| 09597398 | Formulations of bendamustine | Mar 21, 2017 |
| 09597399 | Formulations of bendamustine | Mar 21, 2017 |
| 09579384 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Feb 28, 2017 |
| 09572796 | Formulations of bendamustine | Feb 21, 2017 |
| 09572797 | Formulations of bendamustine | Feb 21, 2017 |
| 09572887 | Formulations of bendamustine | Feb 21, 2017 |
| 09265831 | Formulations of bendamustine | Feb 23, 2016 |
| 09144568 | Formulations of bendamustine | Sep 29, 2015 |
| 09034908 | Formulations of bendamustine | May 19, 2015 |
| 09000021 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Apr 7, 2015 |
| 08609707 | Formulations of bendamustine | Dec 17, 2013 |
